Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Summary: Platelets are central mediators of haemostasis at sites of vascular injury, but they also mediate pathologic thrombosis. Activated platelets stimulate thrombus formation in response to rupture of an atherosclerotic plaque or endothelial cell erosion, promoting atherothrombotic disease. They also interact with endothelial cells and leukocytes to promote inflammation, which contributes to atherosclerosis. Multiple pathways contribute to platelet activation, and current oral antiplatelet therapy with aspirin and a P2Y12 adenosine diphosphate (ADP) receptor antagonist target the thromboxane A2 and ADP pathways, respectively. Both can diminish activation by other factors, but the extent of their effects depends upon the agonist, agonist strength, and platelet reactivity status. Although these agents have demonstrated significant clinical benefit, residual morbidity and mortality remain high. Neither agent is effective in inhibiting thrombin, the most potent platelet activator. This lack of comprehensive inhibition of platelet function allows continued thrombus formation and exposes patients to risk for recurrent thrombotic events. Moreover, bleeding risk is a substantial limitation of antiplatelet therapy, because these agents target platelet activation pathways critical for both protective haemostasis and pathologic thrombosis. Novel antiplatelet therapies that provide more complete inhibition of platelet activation without increasing bleeding risk could considerably decrease residual risk for ischemic events. Inhibition of the protease-activated receptor (PAR)-1 platelet activation pathway stimulated by thrombin is a novel, emerging approach to achieve more comprehensive inhibition of platelet activation when used in combination with current oral antiplatelet agents. PAR-1 inhibition is not expected to increase bleeding risk, as this pathway does not interfere with haemostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“anti-platelet agents are a cornerstone of current pharmacological interventions for the treatment and prevention of acute complications of CVD. These interventions are, however, hampered by their potential for bleeding as a complication”
From Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk (2016) · cites this paper as Jennings, 2009
In the citing paper
“Use of antiplatelet agents has become a cornerstone for the treatment of CVD because of substantial reduction in CVD events and mortality37,38. However, more widespread use of antiplatelet agents has been limited by the increased risk of bleeding, which also leads to nonadherence39–41.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [39]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
Henn, V., Slupsky, J. R., Gräfe, M., Anagnostopoulos, I., Förster, R., Müller-Berghaus, G., & Kroczek, R. A. (1998) · Nature · doi:10.1038/35393 · Cited by 2,078
Sabatine, M. S., Cannon, C. P., Gibson, C. M., López-Sendón, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050522 · Cited by 1,924
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
Lewis, H. D., Davis, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Pouget, J. M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090703 · Cited by 1,709
Platelets in inflammation and atherogenesis
Gawaz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27196 · Cited by 1,468
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Programmed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031
Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes
Rao, S. V. (2004) · JAMA · doi:10.1001/jama.292.13.1555 · Cited by 1,007
Boersma, E., Harrington, R. A., Moliterno, D. J., White, H., Théroux, P., Van de Werf, F., de Torbal, A., Armstrong, P. W., Wallentin, L. C., Wilcox, R. G., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07442-1 · Cited by 991
Variability in Individual Responsiveness to Clopidogrel
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Alfonso, F., Macaya, C., Bass, T. A., & Costa, M. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.044 · Cited by 959
Aspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Bhatt, D. L., Flather, M. D., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.025 · Cited by 805
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
Kindlin-3 is essential for integrin activation and platelet aggregation
Moser, M., Nieswandt, B., Ussar, S., Pozgajova, M., & Fässler, R. (2008) · Nature Medicine · doi:10.1038/nm1722 · Cited by 700
Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105058 · Cited by 697
Schwartz, L., Bourassa, M. G., Lespérance, J., Aldridge, H. E., Kazim, F., Salvatori, V. A., Henderson, M., Bonan, R., & David, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182603 · Cited by 692
Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease
von Hundelshausen, P., & Weber, C. (2007) · Circulation Research · doi:10.1161/01.res.0000252802.25497.b7 · Cited by 681
Structural Basis of Integrin Activation by Talin
Wegener, K. L., Partridge, A. W., Han, J., Pickford, A. R., Liddington, R. C., Ginsberg, M. H., & Campbell, I. D. (2007) · Cell · doi:10.1016/j.cell.2006.10.048 · Cited by 676
Platelet-neutrophil-interactions: Linking hemostasis and inflammation
Zarbock, A., Polanowska-Grabowska, R. K., & Ley, K. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.06.001 · Cited by 651
Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes
Rao, S. V., O’Grady, K., Pieper, K. S., Granger, C. B., Newby, L. K., Van de Werf, F., Mahaffey, K. W., Califf, R. M., & Harrington, R. A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.056 · Cited by 631
Cell Adhesion Mechanisms in Platelets
Varga-Szabo, D., Pleines, I., & Nieswandt, B. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150474 · Cited by 588
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium
von Hundelshausen, P., Weber, K. S. C., Huo, Y., Proudfoot, A. E. I., Nelson, P. J., Ley, K., & Weber, C. (2001) · Circulation · doi:10.1161/01.cir.103.13.1772 · Cited by 584
Platelet Activation and Blood Coagulation
Bevers, E., Lindhout, T., & Heemskerk, J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613209 · Cited by 584
Koenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Bombeli, T., Schwartz, B. R., & Harlan, J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.329 · Cited by 425
Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.
Suh, T. T., Holmbäck, K., Jensen, N. J., Daugherty, C. C., Small, K., Simon, D. I., Potter, S., & Degen, J. L. (1995) · Genes & Development · doi:10.1101/gad.9.16.2020 · Cited by 425
Platelets: signaling cells in the immune continuum
Weyrich, A. S., & Zimmerman, G. A. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.07.003 · Cited by 414
Thrombin and Platelet Activation
Brass, L. F. (2003) · Chest · doi:10.1378/chest.124.3_suppl.18s · Cited by 404
Thrombin functions during tissue factor–induced blood coagulation
Brummel, K. E., Paradis, S. G., Butenas, S., & Mann, K. G. (2002) · Blood · doi:10.1182/blood.v100.1.148 · Cited by 397
Platelet-Endothelial Cell Interactions During Ischemia/Reperfusion: The Role of P-Selectin
Massberg, S., Enders, G., Leiderer, R., Eisenmenger, S., Vestweber, D., Krombach, F., & Messmer, K. (1998) · Blood · doi:10.1182/blood.v92.2.507 · Cited by 393
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
von Hundelshausen, P., Koenen, R. R., Sack, M., Mause, S. F., Adriaens, W., Proudfoot, A. E. I., Hackeng, T. M., & Weber, C. (2005) · Blood · doi:10.1182/blood-2004-06-2475 · Cited by 373
Schober, A., Manka, D., von Hundelshausen, P., Huo, Y., Hanrath, P., Sarembock, I. J., Ley, K., & Weber, C. (2002) · Circulation · doi:10.1161/01.cir.0000028590.02477.6f · Cited by 355
Protein synthesis by platelets: historical and new perspectives
WEYRICH, A. S., SCHWERTZ, H., KRAISS, L. W., & ZIMMERMAN, G. A. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03211.x · Cited by 306
Becker, R. C., Moliterno, D. J., Jennings, L. K., Pieper, K. S., Pei, J., Niederman, A., Ziada, K. M., Berman, G., Strony, J., Joseph, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60230-0 · Cited by 299
Self-citationProtease-Activated Receptors in Cardiovascular Diseases
Leger, A. J., Covic, L., & Kuliopulos, A. (2006) · Circulation · doi:10.1161/circulationaha.105.574830 · Cited by 289
Storey, R. F., Sanderson, H. M., White, A. E., May, J. A., Cameron, K. E., & Heptinstall, S. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02208.x · Cited by 288
Rao, S. V., Eikelboom, J. A., Granger, C. B., Harrington, R. A., Califf, R. M., & Bassand, J.-P. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm019 · Cited by 275
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
NAD(P)H oxidase–dependent platelet superoxide anion release increases platelet recruitment
Krötz, F., Sohn, H. Y., Gloe, T., Zahler, S., Riexinger, T., Schiele, T. M., Becker, B. F., Theisen, K., Klauss, V., & Pohl, U. (2002) · Blood · doi:10.1182/blood.v100.3.917 · Cited by 262
Gawaz, M., Brand, K., Dickfeld, T., Pogatsa-Murray, G., Page, S., Bogner, C., Koch, W., Schömig, A., & Neumann, F.-J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00241-5 · Cited by 258
Expression of Toll-like receptors on human platelets
Shiraki, R., Inoue, N., Kawasaki, S., Takei, A., Kadotani, M., Ohnishi, Y., Ejiri, J., Kobayashi, S., Hirata, K.-I., Kawashima, S., et al. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.03.023 · Cited by 256
Kalbas, M., Willuweit, A., Henn, V., Kroczek, R., Müller-Berghaus, G., & Slupsky, J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615402 · Cited by 241
Binding of Thrombin to Glycoprotein Ib Accelerates the Hydrolysis of Par-1 on Intact Platelets
De Candia, E., Hall, S. W., Rutella, S., Landolfi, R., Andrews, R. K., & De Cristofaro, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008160200 · Cited by 233
Platelet-vessel wall interactions in atherosclerotic disease
Langer, H., & Gawaz, M. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-11-0685 · Cited by 204
Gawaz, M., Neumann, F.-J., Dickfeld, T., Reininger, A., Adelsberger, H., Gebhardt, A., & Schömig, A. (1997) · Circulation · doi:10.1161/01.cir.96.6.1809 · Cited by 203
Defects in hemostasis in P-selectin-deficient mice
Subramaniam, M., Frenette, P., Saffaripour, S., Johnson, R., Hynes, R., & Wagner, D. (1996) · Blood · doi:10.1182/blood.v87.4.1238.bloodjournal8741238 · Cited by 197
Lincoff, A. M., Kereiakes, D. J., Mascelli, M. A., Deckelbaum, L. I., Barnathan, E. S., Patel, K. K., Frederick, B., Nakada, M. T., & Topol, E. J. (2001) · Circulation · doi:10.1161/01.cir.104.2.163 · Cited by 196
Thrombin and protease-activated receptors (PARs) in atherothrombosis
Martorell, L., Rodríguez, C., Gentile, M., Calvayrac, O., Badimon, L., & Martínez-González, J. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0481 · Cited by 195
Platelets: Inflammatory Firebugs of Vascular Walls
May, A. E., Seizer, P., & Gawaz, M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.158915 · Cited by 194
Vandendries, E. R., Hamilton, J. R., Coughlin, S. R., Furie, B., & Furie, B. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610188104 · Cited by 180
Thrombin‐triggered platelet apoptosis
LEYTIN, V., ALLEN, D. J., MYKHAYLOV, S., LYUBIMOV, E., & FREEDMAN, J. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02200.x · Cited by 171
Derian, C. K., Damiano, B. P., Addo, M. F., Darrow, A. L., D’Andrea, M. R., Nedelman, M., Zhang, H.-C., Maryanoff, B. E., & Andrade-Gordon, P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042663 · Cited by 161
Prévost, N., Woulfe, D. S., Jiang, H., Stalker, T. J., Marchese, P., Ruggeri, Z. M., & Brass, L. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404065102 · Cited by 153
Martins, P. A. D. C., van Gils, J. M., Mol, A., Hordijk, P. L., & Zwaginga, J. J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605318 · Cited by 152
Patil, S. P., Newman, D. K., & Newman, P. J. (2001) · Blood · doi:10.1182/blood.v97.6.1727 · Cited by 147
Weyrich, A. S., Denis, M. M., Schwertz, H., Tolley, N. D., Foulks, J. M., Spencer, E. D., Kraiss, L. W., Albertine, K. H., McIntyre, T. M., & Zimmerman, G. A. (2006) · Blood · doi:10.1182/blood-2006-08-042192 · Cited by 137
Role of metalloproteinases in platelet function
Santos-Martínez, M. J., Medina, C., Jurasz, P., & Radomski, M. W. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.06.002 · Cited by 131
Evangelista, V., Manarini, S., Santo, A. D., Capone, M. L., Ricciotti, E., Francesco, L. D., Tacconelli, S., Sacchetti, A., D’Angelo, S. P., Scilimati, A., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000214553.37930.3e · Cited by 127
Platelet Adhesion Enhances the Glycoprotein VI–Dependent Procoagulant Response
Siljander, P. R. M., Farndale, R. W., Feijge, M. A. H., Comfurius, P., Kos, S., Bevers, E. M., & Heemskerk, J. W. M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.618 · Cited by 117
Platelets, leukocytes, and coagulation
Bouchard, B. A., & Tracy, P. B. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200109000-00001 · Cited by 109
Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling
Nanda, N., André, P., Bao, M., Clauser, K. R., DeGuzman, F. R., Howie, D., Conley, P. B., Terhorst, C., & Phillips, D. R. (2005) · Blood · doi:10.1182/blood-2005-01-0333 · Cited by 107
Antithrombotic therapy in patients undergoing percutaneous coronary intervention.
Popma, J., Ohman, E., Weitz, J., Lincoff, A., Harrington, R. A., & Berger, P. (2001) · Chest · doi:10.1378/chest.119.1_suppl.321s · Cited by 104
Impaired “outside-in” integrin αIIbβ3 signaling and thrombus stability in TSSC6-deficient mice
Goschnick, M. W., Lau, L.-M., Wee, J. L. K., Liu, Y. S., Hogarth, P. M., Robb, L., Hickey, M. J., Wright, M. D., & Jackson, D. E. (2006) · Blood · doi:10.1182/blood-2006-02-004267 · Cited by 96
Kato, Y., Kita, Y., Hirasawa-Taniyama, Y., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01973-3 · Cited by 94
Zernecke, A., Liehn, E. A., Fraemohs, L., von Hundelshausen, P., Koenen, R. R., Corada, M., Dejana, E., & Weber, C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000197852.24529.4f · Cited by 78
Clinical implications of clopidogrel resistance
Miguel, A. D., Ibáñez, B., & Badimón, J. J. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-01-0049 · Cited by 76
CD63 modulates spreading and tyrosine phosphorylation of platelets on immobilized fibrinogen
McMillan‐Ward, E., & Israels, S. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0503 · Cited by 65
Leytin, V., Allen, D. J., Lyubimov, E. V., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06503.x · Cited by 58
Cattaneo, M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi851 · Cited by 57
Chemokines and thrombogenicity
Lambert, M. P., Sachais, B. S., & Kowalska, M. A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0046 · Cited by 48
Protease Activated Receptors: Clinical Relevance to Hemostasis and Inflammation
Landis, R. C. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.11.005 · Cited by 48
Novel Therapeutic Targets at the Platelet Vascular Interface
Brass, L. F., Zhu, L., & Stalker, T. J. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.161026 · Cited by 47
Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
Schulman, S. P. (2004) · JAMA · doi:10.1001/jama.292.15.1875 · Cited by 41
Maurice, P., Legrand, C., & Fauvel-Lafève, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-1151com · Cited by 20
Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization
Mondoro, T. H., White, M. M., & Jennings, L. K. (2000) · Blood · doi:10.1182/blood.v96.7.2487 · Cited by 12
Self-citation
Cited by
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8563845 · Cited by 621
Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications
Andrabi, S. M., Sharma, N. S., Karan, A., Shahriar, S. M. S., Cordon, B., Ma, B., & Xie, J. (2023) · Advanced Science · doi:10.1002/advs.202303259 · Cited by 602
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552
Xing, L., Zhang, H., Qi, R., Tsao, R., & Mine, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06146 · Cited by 543
Metadata
- Authors
- Jennings, L.
- Affiliations
- University of Tennessee Health Science Center (US)
- Corresponding author
- Jennings, Lisa
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2009
- Volume
- 102
- Issue
- 08
- Pages
- 248-257
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2071461268
- Cited by
- 436
- References
- 85
- Citations by year
- 2026: 5 · 2025: 21 · 2024: 26 · 2023: 26 · 2022: 25 · 2021: 25 · 2020: 23 · 2019: 27 · 2018: 22 · 2017: 21 · 2016: 25 · 2015: 30 · 2014: 35 · 2013: 33 · 2012: 26
- FWCI
- 20.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- platelet activation, atherothrombosis, antiplatelet therapy, thrombin, protease-activated receptor 1, thromboxane A2, P2Y12 receptor, aspirin, bleeding risk, thrombus formation
- MeSH terms
- Animals, Blood Coagulation, Blood Platelets, Hemostasis, Humans, Inflammation, Leukocytes, Models, Biological, Platelet Aggregation Inhibitors, Thrombosis, Signal Transduction, Platelet Activation, Receptor, PAR-1, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.